Chemokine receptor blockade in graft-versus-host disease

Lancet Oncol. 2012 Aug;13(8):e333. doi: 10.1016/s1470-2045(12)70337-6.
No abstract available

Publication types

  • News

MeSH terms

  • CCR5 Receptor Antagonists*
  • Cyclohexanes / therapeutic use*
  • Graft vs Host Disease / immunology
  • Graft vs Host Disease / prevention & control*
  • Humans
  • Immunologic Factors / therapeutic use*
  • Maraviroc
  • Stem Cell Transplantation / adverse effects*
  • Treatment Outcome
  • Triazoles / therapeutic use*

Substances

  • CCR5 Receptor Antagonists
  • Cyclohexanes
  • Immunologic Factors
  • Triazoles
  • Maraviroc